TY - JOUR
T1 - Effective use of FibroTest to generate decision trees in hepatitis C
AU - Lau-Corona, Dana
AU - Pineda, Luís Alberto
AU - Avilés, Héctor Hugo
AU - Gutiérrez-Reyes, Gabriela
AU - Farfan-Labonne, Blanca Eugenia
AU - Núñez-Nateras, Rafael
AU - Bonder, Alan
AU - Martínez-García, Rosalinda
AU - Corona-Lau, Clara
AU - Olivera-Martínez, Marco Antonio
AU - Gutiérrez-Ruiz, Maria Concepción
AU - Robles-Díaz, Guillermo
AU - Kershenobich, David
PY - 2009/6/7
Y1 - 2009/6/7
N2 - Aim: To assess the usefulness of FibroTest to forecast scores by constructing decision trees in patients with chronic hepatitis C. Methods: We used the C4.5 classification algorithm to construct decision trees with data from 261 patients with chronic hepatitis C without a liver biopsy. The FibroTest attributes of age, gender, bilirubin, apolipo-protein, haptoglobin, α2 macroglobulin, and γ-glutamyl transpeptidase were used as predictors, and the FibroTest score as the target. For testing, a 10-fold cross validation was used. Results: The overall classification error was 14.9% (accuracy 85.1%). FibroTest's cases with true scores of F0 and F4 were classified with very high accuracy (18/20 for F0, 9/9 for F0-1 and 92/96 for F4) and the largest confusion centered on F3. The algorithm produced a set of compound rules out of the ten classification trees and was used to classify the 261 patients. The rules for the classification of patients in F0 and F4 were effective in more than 75% of the cases in which they were tested. Conclusion: The recognition of clinical subgroups should help to enhance our ability to assess differences in fibrosis scores in clinical studies and improve our understanding of fibrosis progression.
AB - Aim: To assess the usefulness of FibroTest to forecast scores by constructing decision trees in patients with chronic hepatitis C. Methods: We used the C4.5 classification algorithm to construct decision trees with data from 261 patients with chronic hepatitis C without a liver biopsy. The FibroTest attributes of age, gender, bilirubin, apolipo-protein, haptoglobin, α2 macroglobulin, and γ-glutamyl transpeptidase were used as predictors, and the FibroTest score as the target. For testing, a 10-fold cross validation was used. Results: The overall classification error was 14.9% (accuracy 85.1%). FibroTest's cases with true scores of F0 and F4 were classified with very high accuracy (18/20 for F0, 9/9 for F0-1 and 92/96 for F4) and the largest confusion centered on F3. The algorithm produced a set of compound rules out of the ten classification trees and was used to classify the 261 patients. The rules for the classification of patients in F0 and F4 were effective in more than 75% of the cases in which they were tested. Conclusion: The recognition of clinical subgroups should help to enhance our ability to assess differences in fibrosis scores in clinical studies and improve our understanding of fibrosis progression.
KW - C4.5 algorithm
KW - Decision trees
KW - FibroTest
KW - Hepatitis C
KW - Non-invasive biomarkers
UR - http://www.scopus.com/inward/record.url?scp=67651152849&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=67651152849&partnerID=8YFLogxK
U2 - 10.3748/wjg.15.2617
DO - 10.3748/wjg.15.2617
M3 - Article
C2 - 19496191
AN - SCOPUS:67651152849
SN - 1007-9327
VL - 15
SP - 2617
EP - 2622
JO - World Journal of Gastroenterology
JF - World Journal of Gastroenterology
IS - 21
ER -